GT-220F

· Geode Therapeutics Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GT-220F, covering 2025-03-10 to 2025-03-10. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Clinical Study of GT-220F in Subjects With Metastatic Castration Resistant Prostate Cancer (mCRPC) [Phase 1]

See pricing